📖

nct07142954

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-nct07142954
Related Entities
clinical-trials-nct07142954
Metadata
slugclinical-trials-nct07142954
entity_typeclinical_trial
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (28)
mentions🧪APOE Isoform Conversion Therapy70%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%
related🧫Cytochrome Therapeutics70%
related🧫Cytochrome Therapeutics70%
related🧪APOE Isoform Conversion Therapy63%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides60%
mentions🧪Competitive APOE4 Domain Stabilization Peptides60%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer54%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides54%
related🧪Competitive APOE4 Domain Stabilization Peptides54%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🧪APOE Isoform Conversion Therapy50%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring44%